Christine Lukacs
- Oncology top 1%
- Cancer-related Molecular Pathways 5
- Molecular Biology top 2%
- Biochemical and Molecular Research 6
- Ubiquitin and proteasome pathways 4
- Protein Kinase Regulation and GTPase Signaling 3
- RNA modifications and cancer 3
- Biotechnology top 1%
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 4
- Cell Biology top 2%
-
- Metabolism and Genetic Disorders 5
-
- Enzyme Structure and Function 3
- Co-authors
- Bradford GravesU. KammlottChristian KleinBinh Thanh VuDaisy CarvajalNader FotouhiFrank PodlaskiZoran Filipovic
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesSwitzerlandHungary
In The Last Decade
Christine Lukacs
34 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 2.5k
- Molecular Biology 3.9k
- Biotechnology 401
- Cancer Research 637
- Cell Biology 484
Countries citing papers authored by Christine Lukacs
This map shows the geographic impact of Christine Lukacs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Lukacs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Lukacs more than expected).
Fields of papers citing papers by Christine Lukacs
This network shows the impact of papers produced by Christine Lukacs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Lukacs. The network helps show where Christine Lukacs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christine Lukacs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2020 | 48 | |
| 3 | 2020 | 91 | |
| 4 | 2019 | 17 | |
| 5 | 2019 | 62 | |
| 6 | 2019 | 35 | |
| 7 | 2019 | 122 | |
| 8 | 2015 | 5 | |
| 9 | 2014 | 222 | |
| 10 | 2013 | 48 | |
| 11 | 2012 | 14 | |
| 12 | 2011 | 20 | |
| 13 | 2010 | 11 | |
| 14 | Design, synthesis of 1,4-cyclohexyldiamine substituted diaminopyrimidines as selective inhibitors of CDK1, CDK2 and CDK4 and their in vitro and in vivo evaluation | 2005 | 1 |
| 15 | In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2breakdown → | 2004 | 3722 |
| 16 | 2003 | 25 | |
| 17 | 2000 | 89 | |
| 18 | 1998 | 56 | |
| 19 | 1996 | 31 | |
| 20 | 1996 | 11 |
About Christine Lukacs
Christine Lukacs is a scholar working on Clinical Biochemistry, Molecular Biology and Cancer Research, having authored 35 papers that have together received 5.3k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (6 papers), Metabolism and Genetic Disorders (5 papers), Cancer-related Molecular Pathways (5 papers), Ubiquitin and proteasome pathways (4 papers), Protease and Inhibitor Mechanisms (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Enzyme Structure and Function (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Oncology (2.5k citations), Molecular Biology (3.9k citations) and Biotechnology (401 citations). Christine Lukacs has collaborated with scholars based in United States, Switzerland and Hungary. Frequent co-authors include Bradford Graves, U. Kammlott, Christian Klein, Binh Thanh Vu, Daisy Carvajal, Nader Fotouhi, Frank Podlaski, Zoran Filipovic, Emily A. Liu and Norman Kong. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.